INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2019

Oral turmeric and curcumin did not significantly lower inflammatory markers in chronic inflammatory conditions.

A systematic review and meta-analysis of 19 randomized controlled trials with follow-ups from 4 to 16 weeks examined oral turmeric (5 trials, n = 356) and curcumin (14 trials, n = 988). Compared to controls, interventions did not significantly lower CRP (MD -2.71 mg/L, 95% CI -5.73 to 0.31), hsCRP (MD -1.44 mg/L, 95% CI -2.94 to 0.06), IL-1 beta, IL-6, or TNF alpha. High heterogeneity was observed for most markers.

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
1,344 patients across 19 randomized controlled trials with chronic inflammatory diseases
What was measured
Inflammatory markers (CRP, hsCRP, IL-1, IL-6, TNF)

THE PAPER

Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials.

White CM, Pasupuleti V, Roman YM, Li Y, Hernandez AV. Pharmacol Res, 2019.

PubMed 31121255 ↗DOI 10.1016/j.phrs.2019.104280 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.